XMED:LSE:LSE-Xtrackers MSCI Europe UCITS ETF 1C (USD)

ETF | Others |

Last Closing

USD 99.67

Change

-0.01 (-0.01)%

Market Cap

USD 4.24B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-1.26 (-0.48%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

-1.51 (-2.40%)

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

+78.00 (+0.87%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

+260.00 (+3.13%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.12 (+0.87%)

USD 652.47B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.11 (+0.65%)

USD 650.46B
0R1I:LSE NVIDIA Corp.

-29.10 (-2.58%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+3.50 (+0.18%)

USD 330.91B

ETFs Containing XMED:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.25% 66% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.25% 65% D 64% D
Trailing 12 Months  
Capital Gain 16.44% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.44% 64% D 66% D+
Trailing 5 Years  
Capital Gain 52.69% 66% D+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.69% 64% D 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.13% 69% C- 71% C-
Dividend Return 9.13% 68% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.29% 40% F 54% F
Risk Adjusted Return 49.92% 66% D+ 78% C+
Market Capitalization 4.24B 94% A 81% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.